CA2374073A1 - Nouveaux polypeptides et acides nucleiques codant ces polypeptides - Google Patents
Nouveaux polypeptides et acides nucleiques codant ces polypeptides Download PDFInfo
- Publication number
- CA2374073A1 CA2374073A1 CA002374073A CA2374073A CA2374073A1 CA 2374073 A1 CA2374073 A1 CA 2374073A1 CA 002374073 A CA002374073 A CA 002374073A CA 2374073 A CA2374073 A CA 2374073A CA 2374073 A1 CA2374073 A1 CA 2374073A1
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- nucleic acid
- novx
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne de nouveaux polynucléotides NOVX isolés et des polypeptides codés par ces polynucléotides NOVX. L'invention concerne également des anticorps qui se fixent de façon immunospécifique sur un polypeptide NOVX ou tout dérivé, variant, mutant ou fragment du polypeptide, polynucléotide ou anticorps NOVX. L'invention concerne également des méthodes dans lesquelles ce polypeptide, ce polynucléotide et cet anticorps NOVX sont utilisés pour détecter et traiter une large gamme d'états pathologiques, ainsi que pour d'autres utilisations.
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19083500P | 2000-03-20 | 2000-03-20 | |
US19076800P | 2000-03-20 | 2000-03-20 | |
US60/190,835 | 2000-03-20 | ||
US60/190,768 | 2000-03-20 | ||
US19097200P | 2000-03-22 | 2000-03-22 | |
US19119900P | 2000-03-22 | 2000-03-22 | |
US60/191,199 | 2000-03-22 | ||
US60/190,972 | 2000-03-22 | ||
US19194700P | 2000-03-24 | 2000-03-24 | |
US60/191,947 | 2000-03-24 | ||
US19298400P | 2000-03-28 | 2000-03-28 | |
US19266500P | 2000-03-28 | 2000-03-28 | |
US19265700P | 2000-03-28 | 2000-03-28 | |
US19266400P | 2000-03-28 | 2000-03-28 | |
US60/192,664 | 2000-03-28 | ||
US60/192,984 | 2000-03-28 | ||
US60/192,665 | 2000-03-28 | ||
US60/192,657 | 2000-03-28 | ||
US19283600P | 2000-03-29 | 2000-03-29 | |
US60/192,836 | 2000-03-29 | ||
US19384300P | 2000-03-31 | 2000-03-31 | |
US60/193,843 | 2000-03-31 | ||
PCT/US2001/009093 WO2001070978A2 (fr) | 2000-03-20 | 2001-03-20 | Nouveaux polypeptides et acides nucleiques codant ces polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2374073A1 true CA2374073A1 (fr) | 2001-09-27 |
Family
ID=27582713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002374073A Abandoned CA2374073A1 (fr) | 2000-03-20 | 2001-03-20 | Nouveaux polypeptides et acides nucleiques codant ces polypeptides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1232266A2 (fr) |
JP (1) | JP2003527859A (fr) |
AU (1) | AU4592001A (fr) |
CA (1) | CA2374073A1 (fr) |
WO (1) | WO2001070978A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003527859A (ja) * | 2000-03-20 | 2003-09-24 | キュラジェン コーポレイション | 新規ポリペプチドおよびそれをコードする核酸 |
AU2001259565A1 (en) * | 2000-05-04 | 2001-11-12 | Incyte Genomics, Inc. | Proteases |
US20010051361A1 (en) * | 2000-05-15 | 2001-12-13 | Wei Shao | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
WO2001096562A1 (fr) * | 2000-06-13 | 2001-12-20 | Merck Patent Gmbh | Recepteurs couples aux proteines g, du type des recepteurs de l'hormone liberant la thyrotropine (gprfwk1) |
WO2001098340A2 (fr) * | 2000-06-23 | 2001-12-27 | Bayer Aktiengesellschaft | Regulation d'une enzyme du type protease mastocytaire humaine 6 |
CN1549858A (zh) * | 2000-11-27 | 2004-11-24 | 阿伦纳药品公司 | 内源和非内源型人g蛋白偶联受体 |
EP1343888A2 (fr) * | 2000-12-14 | 2003-09-17 | Bayer Aktiengesellschaft | Regulation du recepteur humain de type chimiokine |
JPWO2003027142A1 (ja) * | 2001-09-21 | 2005-01-06 | 山之内製薬株式会社 | 新規g蛋白質共役型受容体 |
US8516137B2 (en) * | 2009-11-16 | 2013-08-20 | Microsoft Corporation | Managing virtual hard drives as blobs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5658758A (en) * | 1995-03-24 | 1997-08-19 | Human Genome Sciences Inc | Polynucleotides encoding cytostatin I |
US6063594A (en) * | 1997-01-31 | 2000-05-16 | Incyte Pharmaceuticals, Inc. | DNA encoding a novel human anion channel |
JP2003527859A (ja) * | 2000-03-20 | 2003-09-24 | キュラジェン コーポレイション | 新規ポリペプチドおよびそれをコードする核酸 |
JP2004516817A (ja) * | 2000-07-27 | 2004-06-10 | インサイト・ゲノミックス・インコーポレイテッド | Gタンパク質共役受容体 |
-
2001
- 2001-03-20 JP JP2001569361A patent/JP2003527859A/ja not_active Withdrawn
- 2001-03-20 CA CA002374073A patent/CA2374073A1/fr not_active Abandoned
- 2001-03-20 WO PCT/US2001/009093 patent/WO2001070978A2/fr not_active Application Discontinuation
- 2001-03-20 EP EP01918899A patent/EP1232266A2/fr not_active Withdrawn
- 2001-03-20 AU AU45920/01A patent/AU4592001A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4592001A (en) | 2001-10-03 |
WO2001070978A3 (fr) | 2002-06-27 |
EP1232266A2 (fr) | 2002-08-21 |
WO2001070978A2 (fr) | 2001-09-27 |
JP2003527859A (ja) | 2003-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050287564A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20060063200A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20030185815A1 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
CA2374073A1 (fr) | Nouveaux polypeptides et acides nucleiques codant ces polypeptides | |
US20040002120A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
US20030148485A1 (en) | Novel polypeptides and nucleic acids encoding same | |
CA2448073A1 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
US20030202971A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20030224982A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
CA2442729A1 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation | |
US20040014053A1 (en) | Novel proteins and nucleic acids encoding same | |
US20060211031A1 (en) | Novel proteins and nucleic acids encoding same | |
CA2402248A1 (fr) | Nouveaux polypeptides et acides nucleiques les codant | |
US20030216308A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20040058862A1 (en) | Novel polypeptides and nucleic acids encoding the same | |
US20040029790A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
US20030208039A1 (en) | Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use | |
CA2442739A1 (fr) | Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour ces antigenes, et procedes d'utilisation de ceux-ci | |
WO2002081629A2 (fr) | Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci | |
US20020037850A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20030077774A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20030077794A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20030199465A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20030224367A1 (en) | Novel polypeptides and nucleic acids encoding same | |
US20040010120A1 (en) | Novel polypeptides and nucleic acids encoding same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |